A carregar...
CAR-T cell Therapy for Non-Hodgkin Lymphomas: A New Treatment Paradigm
The majority of patients with B-cell non-Hodgkin lymphoma (NHL) can be cured with standard chemoimmunotherapy. However, patients who fail first line therapy have dismal outcomes, particularly if they have disease that is resistant to salvage therapy, including chemoimmunotherapy, radiation and/or au...
Na minha lista:
| Publicado no: | Adv Cell Gene Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6880960/ https://ncbi.nlm.nih.gov/pubmed/31777773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acg2.54 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|